A recent research review proves NAD+ is a promising therapy for long COVID
Tirzepatide is another GLP-1 option, but its more than just a GLP-1 RA: its also a GIP receptor agonist (GIP RA)
31, 2024 /PRNewswire/ -- Michael Greger, M.D., FACLM, the internationally renowned nutrition expert, physician, founder of NutritionFacts.org, and author of the best-selling books How Not to Die , How Not to Diet , and How Not to Age , turned his attention to the latest research on GLP-1 weight-loss drugs in his new book, OZEMPIC: Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs (Oct 29, 2024), available now on Amazon in softcover and Kindle versions, and on DrGreger.org as an audiobook and ebook
We are expecting additional details for how beneficiaries can sign up for the GLP-1 Bridge program soon, but here is what we know so far: Medicare beneficiaries must be enrolled in a Medicare Part D plan or a Medicare Advantage plan with prescription drug coverage